SARS-CoV-2 genomic surveillance and reliability of PCR single point mutation assay (SNPsig® SARS-CoV-2 EscapePLEX CE) for the rapid detection of variants of concern in Cameroon
© 2024 The Authors..
Background: Surveillance of SARS-CoV-2 variants of concern (VOCs) and lineages is crucial for decision-making. Our objective was to study the SARS-CoV-2 clade dynamics across epidemiological waves and evaluate the reliability of SNPsig® SARS-CoV-2 EscapePLEX CE in detecting VOCs in Cameroon.
Material and methods: A laboratory-based study was conducted on SARS-CoV-2 positive nasopharyngeal specimens cycle threshold (Ct)≤30 at the Chantal BIYA International Reference Centre in Yaoundé-Cameroon, between April-2020 to August-2022. Samples were analyzed in parallel with Sanger sequencing and (SNPsig® SARS-CoV-2 EscapePLEX CE), and performance characteristics were evaluated by Cohen's coefficient and McNemar test.
Results: Of the 130 sequences generated, SARS-CoV-2 clades during wave-1 (April-November 2020) showed 97 % (30/31) wild-type lineages and 3 % (1/31) Gamma-variant; wave-2 (December-2020 to May-2021), 25 % (4/16) Alpha-variant, 25 % (4/16) Beta-variant, 44 % (7/16) wild-type and 6 % (1/16) mu; wave-3 (June-October 2021), 94 % (27/29) Delta-variant, 3 % (1/29) Alpha-variant, 3 % (1/29) wild-type; wave-4 (November-2021 to August-2022), 98 % (53/54) Omicron-variant and 2 % (1/54) Delta-variant. Omicron sub-variants were BA.1 (47 %), BA.5 (34 %), BA.2 (13 %) and BA.4 (6 %). Globally, the two genotyping methods accurately identified the SARS-CoV-2 VOCs (P = 0.17, McNemar test; Ka = 0.67).
Conclusion: Genomic surveillance reveals a rapid dynamic in SARS-CoV-2 strains between epidemiological waves in Cameroon. For wide-spread variant surveillance in resource-limited settings, SNPsig® SARS-CoV-2 EscapePLEX CEkit represents a suitable tool, pending upgrading for distinguishing Omicron sub-lineages.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Heliyon - 10(2024), 7 vom: 15. Apr., Seite e29243 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Cameroon |
|---|
| Anmerkungen: |
Date Revised 25.04.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.heliyon.2024.e29243 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM371123542 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM371123542 | ||
| 003 | DE-627 | ||
| 005 | 20240425234807.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240416s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.heliyon.2024.e29243 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1386.xml |
| 035 | |a (DE-627)NLM371123542 | ||
| 035 | |a (NLM)38623229 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fokam, Joseph |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SARS-CoV-2 genomic surveillance and reliability of PCR single point mutation assay (SNPsig® SARS-CoV-2 EscapePLEX CE) for the rapid detection of variants of concern in Cameroon |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 25.04.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2024 The Authors. | ||
| 520 | |a Background: Surveillance of SARS-CoV-2 variants of concern (VOCs) and lineages is crucial for decision-making. Our objective was to study the SARS-CoV-2 clade dynamics across epidemiological waves and evaluate the reliability of SNPsig® SARS-CoV-2 EscapePLEX CE in detecting VOCs in Cameroon | ||
| 520 | |a Material and methods: A laboratory-based study was conducted on SARS-CoV-2 positive nasopharyngeal specimens cycle threshold (Ct)≤30 at the Chantal BIYA International Reference Centre in Yaoundé-Cameroon, between April-2020 to August-2022. Samples were analyzed in parallel with Sanger sequencing and (SNPsig® SARS-CoV-2 EscapePLEX CE), and performance characteristics were evaluated by Cohen's coefficient and McNemar test | ||
| 520 | |a Results: Of the 130 sequences generated, SARS-CoV-2 clades during wave-1 (April-November 2020) showed 97 % (30/31) wild-type lineages and 3 % (1/31) Gamma-variant; wave-2 (December-2020 to May-2021), 25 % (4/16) Alpha-variant, 25 % (4/16) Beta-variant, 44 % (7/16) wild-type and 6 % (1/16) mu; wave-3 (June-October 2021), 94 % (27/29) Delta-variant, 3 % (1/29) Alpha-variant, 3 % (1/29) wild-type; wave-4 (November-2021 to August-2022), 98 % (53/54) Omicron-variant and 2 % (1/54) Delta-variant. Omicron sub-variants were BA.1 (47 %), BA.5 (34 %), BA.2 (13 %) and BA.4 (6 %). Globally, the two genotyping methods accurately identified the SARS-CoV-2 VOCs (P = 0.17, McNemar test; Ka = 0.67) | ||
| 520 | |a Conclusion: Genomic surveillance reveals a rapid dynamic in SARS-CoV-2 strains between epidemiological waves in Cameroon. For wide-spread variant surveillance in resource-limited settings, SNPsig® SARS-CoV-2 EscapePLEX CEkit represents a suitable tool, pending upgrading for distinguishing Omicron sub-lineages | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cameroon | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a SNPsig®EscapePLEX CE | |
| 650 | 4 | |a Variants of concern | |
| 700 | 1 | |a Gouissi Anguechia, Davy-Hyacinthe |e verfasserin |4 aut | |
| 700 | 1 | |a Takou, Desire |e verfasserin |4 aut | |
| 700 | 1 | |a Jagni Semengue, Ezechiel Ngoufack |e verfasserin |4 aut | |
| 700 | 1 | |a Chenwi, Collins |e verfasserin |4 aut | |
| 700 | 1 | |a Beloumou, Grace |e verfasserin |4 aut | |
| 700 | 1 | |a Djupsa, Sandrine |e verfasserin |4 aut | |
| 700 | 1 | |a Nka, Alex Durand |e verfasserin |4 aut | |
| 700 | 1 | |a Togna Pabo, Willy Le Roi |e verfasserin |4 aut | |
| 700 | 1 | |a Abba, Aissatou |e verfasserin |4 aut | |
| 700 | 1 | |a Ka'e, Aude Christelle |e verfasserin |4 aut | |
| 700 | 1 | |a Kengni, Aurelie |e verfasserin |4 aut | |
| 700 | 1 | |a Etame, Naomi Karell |e verfasserin |4 aut | |
| 700 | 1 | |a Moko, Larissa Gaelle |e verfasserin |4 aut | |
| 700 | 1 | |a Molimbou, Evariste |e verfasserin |4 aut | |
| 700 | 1 | |a Nayang Mundo, Rachel Audrey |e verfasserin |4 aut | |
| 700 | 1 | |a Tommo, Michel |e verfasserin |4 aut | |
| 700 | 1 | |a Fainguem, Nadine |e verfasserin |4 aut | |
| 700 | 1 | |a Fotsing, Lionele Mba |e verfasserin |4 aut | |
| 700 | 1 | |a Colagrossi, Luna |e verfasserin |4 aut | |
| 700 | 1 | |a Alteri, Claudia |e verfasserin |4 aut | |
| 700 | 1 | |a Ngono, Dorine |e verfasserin |4 aut | |
| 700 | 1 | |a Otshudiema, John Otokoye |e verfasserin |4 aut | |
| 700 | 1 | |a Ndongmo, Clement |e verfasserin |4 aut | |
| 700 | 1 | |a Boum, Yap |e verfasserin |4 aut | |
| 700 | 1 | |a Etoundi, Georges Mballa |e verfasserin |4 aut | |
| 700 | 1 | |a Halle, Edie G E |e verfasserin |4 aut | |
| 700 | 1 | |a Eben-Moussi, Emmanuel |e verfasserin |4 aut | |
| 700 | 1 | |a Montesano, Carla |e verfasserin |4 aut | |
| 700 | 1 | |a Marcelin, Anne-Genevieve |e verfasserin |4 aut | |
| 700 | 1 | |a Colizzi, Vittorio |e verfasserin |4 aut | |
| 700 | 1 | |a Perno, Carlo-Federico |e verfasserin |4 aut | |
| 700 | 1 | |a Ndjolo, Alexis |e verfasserin |4 aut | |
| 700 | 1 | |a Ndembi, Nicaise |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Heliyon |d 2015 |g 10(2024), 7 vom: 15. Apr., Seite e29243 |w (DE-627)NLM255913095 |x 2405-8440 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2024 |g number:7 |g day:15 |g month:04 |g pages:e29243 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.heliyon.2024.e29243 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2024 |e 7 |b 15 |c 04 |h e29243 | ||